Journal article · 2019 · Open access
Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale
Journal of Translational Medicine, 17(1), 200 · Published 14 June 2019 · DOI 10.1186/s12967-019-1945-9
In brief
“Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale” is a 2019 journal article by Jie Feng and 4 co-authors, published in Journal of Translational Medicine. OpenAlex counts 137 citations as of 20 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal of Translational Medicine.
- Citations
- 137
- Most cited in
- 2025 (29)
- Field-weighted impact
- 3.08
- References
- 33
- Authors
- 5
Abstract
BACKGROUND: "Nanomedicine" is the application of purposely designed nano-scale materials for improved therapeutic and diagnostic outcomes, which cannot be otherwise achieved using conventional delivery approaches. While "translation" in drug development commonly encompasses the steps from discovery to human clinical trials, a different set of translational steps is required in nanomedicine. Although significant development effort has been focused on nanomedicine, the translation from laboratory formulations up to large scale production has been one of the major challenges to the success of such nano-therapeutics. In particular, scale-up significantly alters momentum and mass transfer rates, which leads to different regimes for the formation of nanomedicines. Therefore, unlike the conventional definition of translational medicine, a key component of "bench-to-bedside" translational research in nanomedicine is the scale-up of the synthesis and processing of the nano-formulation to achieve precise control of the nanoscale properties. This consistency requires reproducibility of size, polydispersity and drug efficacy. METHODS: Here we demonstrate that Flash NanoPrecipitation (FNP) offers a scalable and continuous technique to scale up the production rate of nanoparticles from a laboratory scale to a pilot scale. FNP is a continuous, stabilizer-directed rapid precipitation process. Lumefantrine, an anti-malaria drug, was chosen as a representative drug that was processed into 200 nm nanoparticles with enhanced bioavailability and dissolution kinetics. Three scales of mixers, including a small-scale confined impinging jet mixer, a mid-scale multi-inlet vortex mixer (MIVM) and a large-scale multi-inlet vortex mixer, were utilized in the formulation. The production rate of nanoparticles was varied from a few milligrams in a laboratory batch mode to around 1 kg/day in a continuous large-scale mode, with the size and polydispersity similar at all scales. RESULTS: Nanoparticles of 200 nm were made at all three scales of mixers by operating at equivalent Reynolds numbers (dynamic similarity) in each mixer. Powder X-ray diffraction and differential scanning calorimetry demonstrated that the drugs were encapsulated in an amorphous form across all production rates. Next, scalable and continuous spray drying was applied to obtain dried powders for long-term storage stability. For dissolution kinetics, spray dried samples produced by the large-scale MIVM showed 100% release in less than 2 h in both fasted and fed state intestinal fluids, similar to small-batch low-temperature lyophilization. CONCLUSIONS: These results validate the successful translation of a nanoparticle formulation from the discovery scale to the clinical scale. Coupling nanoparticle production using FNP processing with spray drying offers a continuous nanofabrication platform to scale up nanoparticle synthesis and processing into solid dosage forms.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Feng, J., Markwalter, C. E., Tian, C., Armstrong, M. S., & Prud’homme, R. K. (2019). Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale. Journal of Translational Medicine, 17(1), 200. https://doi.org/10.1186/s12967-019-1945-9
MLA 9
Feng, Jie, et al. “Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.” Journal of Translational Medicine, vol. 17, no. 1, 2019, p. 200. https://doi.org/10.1186/s12967-019-1945-9.
Chicago
Feng, Jie, Chester E. Markwalter, Chang Tian, Madeleine S. Armstrong, and Robert K. Prud’homme. 2019. “Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.” Journal of Translational Medicine 17 (1): 200. https://doi.org/10.1186/s12967-019-1945-9.
Harvard
Feng, J. et al. (2019) ‘Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale’, Journal of Translational Medicine, 17(1), p. 200. doi:10.1186/s12967-019-1945-9.
IEEE
J. Feng, C. E. Markwalter, C. Tian, M. S. Armstrong, and R. K. Prud’homme, “Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale,” Journal of Translational Medicine, vol. 17, no. 1, p. 200, 2019, doi: 10.1186/s12967-019-1945-9.
BibTeX
@article{feng2019translational,
title = {{Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale}},
author = {Feng, Jie and Markwalter, Chester E. and Tian, Chang and Armstrong, Madeleine S. and Prud’homme, Robert K.},
journal = {Journal of Translational Medicine},
year = {2019},
volume = {17},
number = {1},
pages = {200},
doi = {10.1186/s12967-019-1945-9},
url = {https://doi.org/10.1186/s12967-019-1945-9}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2018 | 1 | |
| 2020 | 14 | |
| 2021 | 15 | |
| 2022 | 18 | |
| 2023 | 15 | |
| 2024 | 21 | |
| 2025 | 29 | |
| 2026 | 24 |
Its field-weighted citation impact is 3.08: it has been cited 3.08 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- nanomedicine translation
- continuous precipitation
- spray drying
- amorphous drug encapsulation
- dissolution kinetics
- bioavailability enhancement
- antimalarial drugs
- dynamic similarity
Work with this paper
Most-cited papers in Materials Science
- Electric Field Effect in Atomically Thin Carbon FilmsKostya S. Novoselov, Andre K. Geim, Sergey V. Morozov and 5 more · Science · 2004 · 67,474 citations
- Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenidesROBERT D. SHANNON · Acta Crystallographica Section A · 1976 · 66,944 citations
- Ab initio molecular dynamics for liquid metalsGeorg Kresse, J. Häfner · Physical review. B, Condensed matter · 1993 · 46,320 citations
- Helical microtubules of graphitic carbonSumio Iijima · Nature · 1991 · 43,639 citations
- The rise of grapheneAndre K. Geim, Kostya S. Novoselov · Nature Materials · 2007 · 40,328 citations
Questions about this paper
How do I cite this paper in APA style?
Feng, J., Markwalter, C. E., Tian, C., Armstrong, M. S., & Prud’homme, R. K. (2019). Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale. Journal of Translational Medicine, 17(1), 200. https://doi.org/10.1186/s12967-019-1945-9
How many times has this paper been cited?
137 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Translational Medicine: sign in and open the PDF from this page.
Who wrote this paper?
Jie Feng, Chester E. Markwalter, Chang Tian, Madeleine S. Armstrong, Robert K. Prud’homme.
What is the DOI of this paper?
10.1186/s12967-019-1945-9, permanently at https://doi.org/10.1186/s12967-019-1945-9. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.